Related Experiment Video
Updated: Jul 24, 2025
07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
7.0K
Breaking down the tumor immune infiltration within pediatric sarcomas
Rachel Weil1,2, David Loeb1,2
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, United States.
Frontiers in Endocrinology
|July 10, 2023
Summary
Immunotherapies show promise but face challenges in treating sarcomas due to the immunosuppressive tumor microenvironment (TME). Understanding TME components and cell interactions is key to developing effective sarcoma immunotherapies.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Immunotherapies offer a promising treatment avenue for various cancers.
- Sarcomas, a diverse group of cancers, have shown limited response to current immunotherapies.
- The tumor microenvironment (TME) in sarcomas presents significant barriers to effective immunotherapy.
Purpose of the Study:
- To investigate the reasons behind the limited success of immunotherapies in sarcomas.
- To explore the role of the immunosuppressive tumor microenvironment (TME) in sarcoma progression.
- To identify strategies for improving immunotherapy outcomes in sarcoma patients.
Main Methods:
- Analysis of the immunosuppressive factors within the sarcoma TME.
- Examination of cellular interactions within the complex immune microenvironment of sarcomas.
- Deconstruction of the TME into its individual cellular components.
Main Results:
- Sarcomas exhibit an immunosuppressive TME that hinders immunotherapy efficacy.
- Key factors contributing to treatment failure include lack of predictive biomarkers, decreased T-cell clonal frequency, and high expression of immunosuppressive infiltrating cells.
- The complex interplay of cellular components within the TME is a critical determinant of treatment response.
Conclusions:
- A deeper understanding of the sarcoma TME is crucial for advancing immunotherapy.
- Targeting specific components and interactions within the TME can overcome resistance to immunotherapy.
- Developing effective immunotherapies for sarcomas may improve outcomes for patients with metastatic disease.
Related Concept Videos
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K